Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clarification on neuromuscular conditions in careers article.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.
Disability in multiple sclerosis: A reference for patients and clinicians.
TNFRSF1A polymorphisms and MS: Statistical signals transform into pathogenetic mechanisms.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Self-intermittent catheterization in multiple sclerosis.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
[Neurology at the border of centuries: achievements and prospects].
Pages
« first
‹ previous
…
330
331
332
333
334
335
336
337
338
…
next ›
last »